Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer
This study has been completed.
Study NCT00331786. Last updated on July 23, 2008.
Information provided by National Cancer Institute (NCI)
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Additional conditions recognized in this trial
Colorectal Neoplasms
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases
Interventions listed in this trial
biopsy
laboratory biomarker analysis
Additional drug interventions recognized in this trial
Aspirin
Nitric Oxide
Nitroaspirin
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antioxidants
Antirheumatic Agents
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Cysteine Proteinase Inhibitors
Endothelium-Dependent Relaxing Factors
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Free Radical Scavengers
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Protease Inhibitors
Protective Agents
Respiratory System Agents
Sensory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Stony Brook University
National Cancer Institute (NCI)
Back to top of Main Content
